Archive for the ‘Nephrogenic Fibrosing Dermopathy’ Category

March 23, 2010

The Outcome of Patients with Nephrogenic Systemic Fibrosis after Successful Kidney Transplantation

Leung N, Shaikh A, Cosio FG, Griffin MD, Textor SC, Gloor JM, Schwab TR, Larson TS, Dean PG, Prieto M, Nyberg SL, Stegall MD, Lee CU, Pittelkow MR.   Am J Transplant.   2010 Mar;10(3):558-62

Nephrogenic systemic fibrosis (NSF) is a severe dermopathy that occurs in patients with renal failure and have been exposed to contrast agents containing gadolinium. This study reviews 17 patients with NSF, 11 of whom received a kidney transplant. Transplantation did not lead to complete reversal of the changes of NSF.

No Comments Posted in Nephrogenic Fibrosing Dermopathy, Renal Transplantation
May 1, 2008

Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease.

Perazella MA, Reilly RF.   Semin Dial.   2008 Mar-Apr;21(2):171-3

No Comments Posted in Nephrogenic Fibrosing Dermopathy
December 1, 2007

What nephrologists need to know about gadolinium.

Penfield JG, Reilly RF Jr.   Nat Clin Pract Nephrol.   2007 Dec;3(12):654-68

No Comments Posted in Nephrogenic Fibrosing Dermopathy
August 1, 2007

Nephrogenic Fibrosing Dermopathy

Garovic VD, Helgen KE.   N Engl J Med.   2007 Jul 12;357(2):e2

No Comments Posted in Nephrogenic Fibrosing Dermopathy
April 1, 2007

Nephrogenic Systemic Fibrosis: A Population Study Examining the Relationship of Disease Development to Gadolinium Exposure.

Deo A, Fogel M, Cowper SE.   Clin J Am Soc Nephrol.   2007 Mar;2(2):264-7

No Comments Posted in Nephrogenic Fibrosing Dermopathy
February 1, 2007

Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis.

Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE.   Radiology.   2007 Mar;242(3):647-9

No Comments Posted in Nephrogenic Fibrosing Dermopathy
February 1, 2007

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.

Weiss AS, Lucia MS, Teitelbaum I.   Nat Clin Pract Nephrol.   2007 Feb;3(2):111-5

No Comments Posted in Nephrogenic Fibrosing Dermopathy
January 1, 2007

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging.

Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS.   J Am Soc Nephrol.   2006 Sep;17(9):2359-62

No Comments Posted in Nephrogenic Fibrosing Dermopathy